Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Equine Pharmaceuticals & Supplements Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Pharmaceutical, Supplement)
5.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
5.2.3. By Region
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Distribution Channel
5.3.3. By Region
6. North America Equine Pharmaceuticals & Supplements Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Pharmaceutical, Supplement)
6.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Equine Pharmaceuticals & Supplements Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Distribution Channel
6.3.2. Canada Equine Pharmaceuticals & Supplements Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Distribution Channel
6.3.3. Mexico Equine Pharmaceuticals & Supplements Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Distribution Channel
7. Europe Equine Pharmaceuticals & Supplements Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Pharmaceutical, Supplement)
7.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Equine Pharmaceuticals & Supplements Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Distribution Channel
7.3.2. United Kingdom Equine Pharmaceuticals & Supplements Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Distribution Channel
7.3.3. France Equine Pharmaceuticals & Supplements Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Distribution Channel
7.3.4. Italy Equine Pharmaceuticals & Supplements Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Distribution Channel
7.3.5. Spain Equine Pharmaceuticals & Supplements Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Distribution Channel
8. Asia-Pacific Equine Pharmaceuticals & Supplements Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Pharmaceutical, Supplement)
8.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Equine Pharmaceuticals & Supplements Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Distribution Channel
8.3.2. Japan Equine Pharmaceuticals & Supplements Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Distribution Channel
8.3.3. India Equine Pharmaceuticals & Supplements Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Distribution Channel
8.3.4. Australia Equine Pharmaceuticals & Supplements Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Distribution Channel
8.3.5. South Korea Equine Pharmaceuticals & Supplements Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Distribution Channel
9. South America Equine Pharmaceuticals & Supplements Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Pharmaceutical, Supplement)
9.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Equine Pharmaceuticals & Supplements Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Distribution Channel
9.3.2. Argentina Equine Pharmaceuticals & Supplements Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Distribution Channel
9.3.3. Colombia Equine Pharmaceuticals & Supplements Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Distribution Channel
10. Middle East and Africa Equine Pharmaceuticals & Supplements Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Pharmaceutical, Supplement)
10.2.2. By Distribution Channel (Drug Stores, Veterinary Hospitals, Others)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Equine Pharmaceuticals & Supplements Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Distribution Channel
10.3.2. Saudi Arabia Equine Pharmaceuticals & Supplements Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Distribution Channel
10.3.3. UAE Equine Pharmaceuticals & Supplements Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Distribution Channel
10.3.4. Kuwait Equine Pharmaceuticals & Supplements Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter?s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Zoetis Inc
14.6.2. Boehringer Ingelheim GmbH
14.6.3. Merck & Co Inc
14.6.4. Elanco Animal Health Inc
14.6.5. Bayer AG
14.6.6. Ceva Sante Animale SA
14.6.7. Virbac SA
14.6.8. Vetoquinol SA
14.6.9. Affymetrix Inc
14.6.10. Celltrion Inc
15. Strategic Recommendations
16. About Us & Disclaimer